- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
MGMT Antibody IDD-13 / O6-Methylguanine DNA Methyltransferase Antibody recognizes MGMT, a DNA repair enzyme that protects genomic integrity by directly reversing alkylation damage at the O6 position of guanine. Also known as O6-alkylguanine DNA alkyltransferase (AGT), MGMT transfers alkyl groups from damaged DNA to a conserved cysteine residue within its active site. This reaction restores the original guanine base without requiring nucleotide excision or replacement. Because each repair event irreversibly inactivates one MGMT molecule, the enzyme is classified as a suicide DNA repair protein and must be replenished through new protein synthesis.
MGMT plays a critical role in cellular resistance to alkylating agents, including the chemotherapy drug temozolomide. By removing O6-methylguanine lesions before they trigger mismatch repair-dependent cytotoxic responses, MGMT can protect tumor cells from treatment-induced DNA damage. Elevated MGMT expression is associated with resistance to alkylating chemotherapy, particularly in glioblastoma and other malignancies. Conversely, reduced MGMT activity can increase cellular sensitivity to these agents, making the enzyme an important focus of cancer biology and therapeutic research.
MGMT expression is regulated through transcriptional and epigenetic mechanisms, including methylation of CpG sites within its promoter region. MGMT promoter hypermethylation is frequently associated with transcriptional silencing and reduced protein expression. In glioblastoma, promoter methylation has clinical significance as a predictive biomarker for responsiveness to temozolomide-based treatment. However, promoter methylation status and MGMT protein abundance do not always correlate directly, reflecting additional influences from tumor heterogeneity, transcriptional regulation, and protein turnover. These distinctions highlight the importance of investigating MGMT at multiple levels of biological regulation.
MGMT is predominantly localized to the nucleus, where it protects DNA from mutagenic alkylation damage. Its expression varies among normal tissues and tumors, influencing cellular repair capacity and susceptibility to genotoxic stress. MGMT Antibody IDD-13 provides a means of examining MGMT protein expression in studies of DNA repair, tumor biology, and chemotherapy resistance, supporting investigations into the mechanisms that determine cellular responses to alkylating agents.
Additional Cell Biology Antibodies are available for investigating DNA damage responses, genome maintenance, and cellular repair mechanisms.
Optimal dilution of the MGMT Antibody IDD-13 / O6-Methylguanine DNA Methyltransferase Antibody should be determined by the researcher.
A synthesized peptide derived from human Methylated-DNA--protein-cysteine methyltransferase protein was used as the immunogen for the MGMT Antibody IDD-13.
The MGMT Antibody IDD-13 can be stored at -20oC.
O6-methylguanine DNA methyltransferase antibody, O6-alkylguanine DNA alkyltransferase antibody, DNA repair methyltransferase antibody, O6-methylguanine repair protein antibody, AGT antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.